These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24785978)

  • 1. Persistent lipid abnormalities in patients with hypertension and dyslipidemia treated with statins: results of the Portuguese hypertensive subpopulation of the Dyslipidemia International Study (DYSIS).
    Silva PM; Cardoso SM; Ferreira AM
    Clin Exp Hypertens; 2015; 37(2):116-21. PubMed ID: 24785978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS).
    Marques da Silva P; Massano Cardoso S; Ferreira AM;
    Prim Care Diabetes; 2015 Aug; 9(4):283-9. PubMed ID: 25449144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent lipid abnormalities in patients treated with statins: Portuguese results of the Dyslipidemia International Study (DYSIS).
    da Silva PM; Cardoso SM;
    Rev Port Cardiol; 2011 Jan; 30(1):47-63. PubMed ID: 21425743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].
    Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR
    Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain. DYSIS-Spain Study].
    González-Juanatey JR; Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC
    Rev Esp Cardiol; 2011 Apr; 64(4):286-94. PubMed ID: 21411216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany.
    Gitt AK; Jünger C; Smolka W; Bestehorn K
    Clin Res Cardiol; 2010 Nov; 99(11):723-33. PubMed ID: 20521058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China.
    Wei Y; Guo H; The E; Che W; Shen J; Hou L; Zhao S; Ye P; Li G; Wang D; Jie Q; Hu D
    Int J Cardiol; 2015 Mar; 182():469-75. PubMed ID: 25612824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.
    Shalev V; Goldshtein I; Halpern Y; Chodick G
    Pharmacotherapy; 2014 Jan; 34(1):1-8. PubMed ID: 23836549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study.
    Azar ST; Hantash HA; Jambart S; El-Zaheri MM; Rachoin R; Chalfoun A; Lahoud L; Okkeh O; Bramlage P; Brudi P; Ambegaonkar BM
    Vasc Health Risk Manag; 2014; 10():225-35. PubMed ID: 24872710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands. Part of the dyslipidaemia international survey.
    Strang AC; Kaasjager HA; Basart DC; Stroes ES
    Neth J Med; 2010 Apr; 68(4):168-74. PubMed ID: 20421658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS).
    Drexel H; Chazelle F; Fauer C; Lautsch D; Gitt AK
    Wien Klin Wochenschr; 2011 Oct; 123(19-20):611-7. PubMed ID: 21947362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): results of the Dyslipidemia International Study (DYSIS).
    Viigimaa M; Erglis A; Latkovskis G; Mäeots E; Petrulionienė Ž; Šlapikas R; Gocentiene A; Bramlage P; Brudi P
    Medicina (Kaunas); 2014; 50(1):44-53. PubMed ID: 25060204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
    Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D;
    Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment.
    Al Sifri SN; Almahmeed W; Azar S; Okkeh O; Bramlage P; Jünger C; Halawa I; Ambegaonkar B; Wajih S; Brudi P
    PLoS One; 2014; 9(1):e84350. PubMed ID: 24400085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and association with diabetes and obesity of lipid phenotypes among the hypertensive Chinese rural adults.
    Zhang X; Sun Z; Zhang D; Zheng L; Li J; Liu S; Xu C; Li J; Hu D; Sun Y
    Heart Lung; 2009; 38(1):17-24. PubMed ID: 19150527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the era of the universal use of statins dyslipidemia's are still common in heart transplant recipients: a cross-sectional study.
    Zakliczynski M; Boguslawska J; Wojniak E; Zakliczynska H; Ciesla D; Nozynski J; Szygula-Jurkiewicz B; Zeglen S; Zembala M
    Transplant Proc; 2011 Oct; 43(8):3071-3. PubMed ID: 21996228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
    Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.